Dear Task Force Colleagues, I am pleased to announce that we have completed major revision on the draft community group note on the topic of a potential drug-drug interaction (PDDI) minimum information model. The content of the note is not very different from prior versions but the organization and format is considerably changed with the goal of making it a much more usable report for a technical audience. I have checked with the other editors on this note and have received very positive feedback. I am asking all contributors for any final feedback before we officially publish as W3C Community Group Note. You can view the note here: - Temporary web location (what the note will ultimately look like): https://dbmi-icode-01.dbmi.pitt.edu/dikb-evidence/hcls-drug-drug-interaction/index.html - Word and PDF versions in case you want to make edits/comments (please note that the final version of this will be rendered as shown on the web version) Please reply directly to me or on the Community Group mailing list (public-hclscg@w3.org) with any comments, edits, or concerns within three weeks (by May 17th). Please ensure that your name and affiliation is written correctly. Also, an funding acknowledgement that needs mentioned. thanks a bunch! -Rich -- Richard D Boyce, PhD Associate Professor of Biomedical Informatics and Clinical and Translational Science in the Clinical and Translational Science Institute Director of the Informatics Core for the Center of Excellence for Natural Product- Drug Interaction Research (NaPDI) Faculty, Center for Pharmaceutical Policy and Prescribing Faculty, Geriatric Pharmaceutical Outcomes and Gero-Informatics Research and Training Program University of Pittsburgh rdb20@pitt.edu Office: 412-648-9219 Twitter: @bhaapgh
This archive was generated by hypermail 2.4.0 : Friday, 17 January 2020 17:22:08 UTC